Clinical understanding and clinical implications of response shift

Social Science and Medicine

Volumn 48, Issue 11, 1999, Pages 1577-1588

  Wilson, Ira B ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Hypochondriasis; Physician patient relationship; Placebo effects; Somatization

Indexed keywords

AGED; CASE REPORT; CLINICAL MEDICINE; CONFERENCE PAPER; DOCTOR PATIENT RELATION; HEALTH BEHAVIOR; HUMAN; HYPOCHONDRIASIS; MALE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SOCIAL ASPECT; SOCIAL BEHAVIOR; SOMATIZATION;

ADAPTATION, PSYCHOLOGICAL; HEALTH STATUS; HUMANS; MODELS, THEORETICAL; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN-PATIENT RELATIONS; QUALITY OF LIFE;

EID: 0033023538     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0277-9536(99)00050-7     Document Type: Conference Paper

References (74)

1. Diagnostic and Statistical Manual of Mental Disorders. 1994;The American Psychiatric Association, Washington, DC.
2. Armenakis A.A. A review of research on the change typology. Woodman R.W., Pasmore W.A. Research in Organization Change and Development. 1988;163-194 JAI Press, Greenwich, CT.
3. Backett E.M., Heady J.A., Evans J.C.G. Studies of a general practice (II): the doctor's job in an urban area. British Medical Journal. 1:1954;109-115.
4. Balint M. The Doctor, the Patient and the Illness. 1957;Pitman Medical Publishing Co, London.
5. Barsky A.J. Amplification, somatization and the somatoform disorders. Psychosomatics. 33:1992;28-34.
6. Barsky A.J., Borus J.F. Somatization and medicalization in the era of managed care. JAMA. 274:1995;1931-1934.
7. Barsky A.J., Geringer E., Wool C. A cognitive-educational treatment for hypochondriasis. General Hospital Psychiatry. 10:1988;322-327.
8. Beecher H.K. The powerful placebo. JAMA. 159:1955;1602-1606.
9. Bombardier C., Ware J., Larson M., Chalmers A., Read J.L. Auranofin therapy and quality of life in patients with rheumatoid arthritis. The American Journal of Medicine. 81:1986;565-578.
10. Bradley J.D., Brandt K.D., Katz B.P., Kalasinski L.A., Ryan S.I. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen and acetaminophen in the treatment of patients with osteoarthritis of the knee. The New England Journal of Medicine. 325:1991;87-91.
11. Brody H. Placebo effect: an examination of Grunbaum's definition. White L., Tursky B., Schwartz G.E. Placebo: Theory, Research, and Mechanism. 1985;37-58 The Guilford Press, New York.
12. Chaput de Saintonge D.M., Herxheimer A. Harnessing placebo effects in health care. The Lancet. 344:1994;995-998.
13. Chesney M., Folkman S., Chambers D. Coping effectiveness training for men living with HIV: preliminary findings. International Journal of STD and AIDS. 7(Suppl. 2):1996;75-82.
14. Cleary P.D., Wilson I.B., Fowler F.J. A theoretical framework for assessing and analyzing health-related quality of life. Albrecht G. Advances in Medical Sociology. 1994;23-41 JAI Press, Greenwich, CT.
15. Cleary P.D., Wilson I.B., Fowler F.J. Jr. Health-related quality of life in HIV-infected persons: a conceptual model. Dimsdale J.E., Baum A. Quality of Life in Behavioral Research. 1995;191-204 Lawrence Erlbaum Associates, Publishers, Hillsdale, NJ.
16. Croog S.H., Levine S., Testa M.A.et al. The effects of antihypertensive therapy on the quality of life. The New England Journal of Medicine. 314:1996;1657-1664.
17. Donabedian A. The Definition of Quality and Approaches to its Assessment. 1980;Health Administration Press, Ann Arbor, MI.
18. Eisenberg D.M., Kessler R.C., Forster C. rlock, Norlock F.E., Calkins D.R., Delbanco T.L. Unconventional medicine in the United States: prevalence, costs, and patterns of use. The New England Journal of Medicine. 328:1993;246-252.
19. Eisenberg L. Disease and illness: distinctions between professional and popular ideas of sickness. Culture, Medicine and Psychiatry. 1:1977;9-23.
20. Ellwood P.M. Shattuck lecture, outcomes management: a technology of patient experience. The New England Journal of Medicine. 318:1988;1549-1556.
21. Folkman S., Chesney M.A., Christopher-Richards A. Stress and coping in caregiving partners of men with AIDS. Psychiatric Clinics of North America. 17:1994;35-53.
22. Freund P.E.S., McGuire M. Health, Illness, and the Social Body. 1991;Prentice Hall, Englewood Cliffs, NJ.
23. Ganz P.A. Quality of life and the patient with cancer. Individual and policy implications. Cancer. 74:1994;1445-1452.
24. Garfield S.R., Collen M.F., Feldman R., Soghikian K., Richart R.H., Duncan J.H. Evaluation of an ambulatory medical-care delivery system. The New England Journal of Medicine. 294:1976;426-431.
25. Gelber R.D., Lenderking W.R., Cotton D.J.et al. Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. Annals of Internal Medicine. 116:1992;961-966.
26. Golembiewski R.T., Billingsley K., Yeager S. Measuring change and persistence in human affairs: types of change generated by OD designs. Journal of Applied Behavioral Science. 12:1976;133-157.
27. Gotzsche P.C. Is there logic in the placebo. The Lancet. 344:1994;925-926.
28. Gough H.G. Doctors' estimates of the percentage of patients whose problems do not require medical attention. Medical Education. 11:1977;380-384.
29. Greenfield S., Kaplan S.H., Ware J.E. Expanding patient involvement in care: effects on patient outcomes. Annals of Internal Medicine. 102:1985;520-528.
30. Greenfield S., Kaplan S.H., Ware J.E., Yano E.M., Frank H.J.L. Patients' participation in medical care: effects on blood sugar control and quality of life in diabetes. Journal of General Internal Medicine. 3:1988;448-457.
31. Grunbaum A. Explication and implications of the placebo concept. White L., Tursky B., Schwartz G.E. Placebo: Theory, Research, and Mechanism. 1985;9-36 The Guilford Press, New York.
32. Guyatt G.H., Feeny D.H., Patrick D.L. Measuring health-related quality of life. Annals of Internal Medicine. 118:1993;622-629.
33. Hahn R.A. A sociocultural model of illness and healing. White L., Tursky B., Schwartz G.E. Placebo: Theory, Research, and Mechanisms. 1985;167-195 The Guilford Press, New York.
34. Helman C.G. Culture, Health and Illness. 1994;Butterworth-Heinemann, Oxford.
35. Hilkevitch, A., 1965. Psychiatric disturbances in outpatients of a general medical outpatient clinic. International Journal of Neuropsychiatry 1, 371-375.
36. Isselbacher K.J., Braunwald E., Wilson J., Martin J.B., Fauci A., Kasper D.L. Harrison's Principles of Internal Medicine. 1994;McGraw-Hill, New York.
37. Jacobson A., Cleary P., Baker L. The effect of intensive treatment on quality of life outcomes in the Diabetes Treatment and Complications Trial. Diabetes Care. 19:1996;195-203.
38. Kaplan S.H., Greenfield S., Ware J.E. Jr. Impact of the doctor-patient relationship on the outcomes of chronic disease. Stewart M., Roter D. Communicating With Medical Patients. 1989;228-245 Sage Publications, Newbury Park.
39. Kaplan S.H., Ware J. The patient's role in health care and quality assessment. Goldfield N., Nash D.B. Providing Quality Care: Future Challenges. 1995;25-57 Health Administration Press, Ann Arbor, MI.
40. Kellner R. Hypochondriasis and somatization. JAMA. 258:1987;2718-2722.
41. Kellner R. Diagnosis and treatments of hypochondriacal syndromes. Psychosomatics. 33:1992;278-289.
42. Kleijnen J., de Craen A.J.M., van Everdingen J. J.a, Krol L. Placebo effect in double-blind clinical trials: a review of interactions with medications. The Lancet. 344:1994;1347-1349.
43. Kleinman A., Eisenberg L., Good B. Culture, illness, and care: lessons from anthropoligic and cross-cultural research. Annals of Internal Medicine. 88:1978;251-258.
44. Kroenke K., Arrington M.E., Mangelsdorff A.D. The prevalence of symptoms in medical outpatients and the adequacy of therapy. Archives of Internal Medicine. 150:1990;1685-1689.
45. Kroenke K., Mangelsdorff A.D. Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. The American Journal of Medicine. 86:1989;262-266.
46. Laporte J., Figueras A. Placebo effects in psychiatry. The Lancet. 344:1994;1206-1209.
47. Lenderking W.R., Gelber R.D., Cotton D.J.et al. Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The New England Journal of Medicine. 330:1994;738-744.
48. Lipkin M. Jr., Putnam S.M., Lazare A. The Medical Interview: Clinical Care, Education, and Research. 1995;Springer-Verlag, New York.
49. Lipowski Z.J. Somatization: the concept and its clinical application. American Journal of Psychiatry. 145:1988;1358-1368.
50. Lubeck D.P., Fries J.F. Health status among persons infected with human immunodeficiency virus: a community-based study. Medical Care. 31:1993;269-276.
51. McDowell I., Newell C. Measuring Health: a Guide to Rating Scales and Questionnaires. 1996;Oxford University Press, New York.
52. Mechanic D. Social psychologic factors affecting the presentation of bodily complaints. The New England Journal of Medicine. 286:1972;1132-1139.
53. Mechanic D. Symptoms, Illness Behavior, and Help-seeking. 1982;Prodist, New York.
54. Norman P., Parker S. The interpretation of change in verbal reports: implications for health psychology. Psychology and Health. 11:1996;301-314.
55. Novack D.H. Therapeutic aspects of the clinical encounter. Lipkin M. Jr., Putnam S.M., Lazare A. The Medical Interview: Clinical Care, Education, and Research. 1995;Springer-Verlag, New York.
56. Patrick D.L., Erickson P. Health Status and Health Policy: Allocating Resources to Health Care. 1993;Oxford University Press, New York.
57. Pilowsky I., Smith Q.P., Katsikitis M. Illness behaviour and general practice utilization: a prospective study. Journal of Psychosomatic Research. 31:1987;177-183.
58. Rawlinson M.C. Truth-telling and paternalism in the clinic: philosophical reflections on the use of placebos in medical practice. White L., Tursky B., Schwartz G.E. Placebo: Theory, Research, and Mechanism. 1985;403-418 The Guilford Press, New York.
59. Roter D.L., Hall J.A. Doctors talking with Patients. Patients talking with Doctors. 1992;Auburn House, Westport, CT.
60. Schwartz, C.E., Sprangers, M.A.G., 1999. Integrating response shift into health-related quality of life research: a theoretical model. Social Science and Medicine 48, 1507-1515.
61. Smith T.C., Thompson T.L. II The inherent powerful therapeutic value of a good physician-patient relationship. Psychosomatics. 34:1993;166-170.
62. Stewart M., Roter D. Communicating with Medical Patients. 1989;Sage Publications, Newbury Park, CA.
63. Strauss J.L., Cavanaugh S.V. Placebo effects: issues for clinical practice in psychiatry and medicine. Psychosomatics. 37:1996;315-326.
64. Testa M.A., Anderson R.B., Nackley J.F., Hollenberg N.K. Quality of life and antihypertensive therapy in men: a comparison of captopril with enalapril. The New England Journal of Medicine. 328:1993;907-913.
65. Testa M.A., Simonson D.C. Assessment of quality-of-life outcomes. The New England Journal of Medicine. 334:1996;835-840.
66. Thomas K.B. The placebo in general practice. The Lancet. 344:1994;1066-1067.
67. Turner J.A., Deyo R.A., Loeser J.D., Von Korff M., Fordyce W.E. The importance of placebo effects in pain treatment and research. JAMA. 271:1994;1609-1614.
68. Verbrugge L.M., Ascione F.J. Exploring the iceberg: common symptoms and how people care for them. Medical Care. 25:1987;539-569.
69. Weinberger M., Kirkman M.S., Samsa G.P.et al. The relationship between glycemic control and health-related quality of life in patients with non-insulin-dependent diabetes mellitus. Medical Care. 32:1994;1173-1181.
70. White K.L., Williams T.F., Greenberg B.G. The ecology of medical care. The New England Journal of Medicine. 265:1961;885-892.
71. White L., Tursky B., Schwarz G.E. Placebo: Theory, Research, and Mechanisms. 1985;The Guilford Press, New York.
72. Wilson J.F. Patients, and money, compelling doctors to look at alternative medicine. ACP Observer. 17:1997;1.
73. Wilson I.B., Cleary P.D. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA. 273:1995;59-65.
74. Wilson I.B., Kaplan S. Clinical practice and patients' health status: how are the two related? Medical Care. 33:1995;AS209-AS214.